Literature DB >> 20730871

Atypical molecular profile for joint development in the avian costal joint.

B B Winslow1, A C Burke.   

Abstract

Development of synovial joints involves generation of cartilaginous anlagen, formation of interzones between cartilage anlagen, and cavitation of interzones to produce fluid filled cavities. Interzone development is not fully understood, but interzones are thought to develop from skeletogenic cells that are inhibited from further chondrogenic development by a cascade of gene expression including Wnt and Bmp family members. We examined the development of the rarely studied avian costal joint to better understand mechanisms of joint development. The costal joint is found within ribs, is morphologically similar to the metatarsophalangeal joint, and undergoes cavitation in a similar manner. In contrast to other interzones, Wnt14/9a, Gdf5, Chordin, Barx1, and Bapx1 are absent from the costal joint interzone, consistent with the absence of active β-catenin and phosphorylated Smad 1/5/8. However Autotaxin and Noggin are expressed. The molecular profile of the costal joint suggests there are alternative mechanisms of interzone development.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20730871      PMCID: PMC2967702          DOI: 10.1002/dvdy.22388

Source DB:  PubMed          Journal:  Dev Dyn        ISSN: 1058-8388            Impact factor:   3.780


  52 in total

1.  Wnt-14 plays a pivotal role in inducing synovial joint formation in the developing appendicular skeleton.

Authors:  C Hartmann; C J Tabin
Journal:  Cell       Date:  2001-02-09       Impact factor: 41.582

2.  Sensitive nonradioactive detection of mRNA in tissue sections: novel application of the whole-mount in situ hybridization protocol.

Authors:  A F Moorman; A C Houweling; P A de Boer; V M Christoffels
Journal:  J Histochem Cytochem       Date:  2001-01       Impact factor: 2.479

3.  The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6.

Authors:  Haruhiko Akiyama; Marie-Christine Chaboissier; James F Martin; Andreas Schedl; Benoit de Crombrugghe
Journal:  Genes Dev       Date:  2002-11-01       Impact factor: 11.361

4.  Expression of chick Barx-1 and its differential regulation by FGF-8 and BMP signaling in the maxillary primordia.

Authors:  A J Barlow; J P Bogardi; R Ladher; P H Francis-West
Journal:  Dev Dyn       Date:  1999-04       Impact factor: 3.780

5.  A role for the BMP antagonist chordin in endochondral ossification.

Authors:  Donghui Zhang; Cristin M Ferguson; Regis J O'Keefe; J Edward Puzas; Randy N Rosier; Paul R Reynolds
Journal:  J Bone Miner Res       Date:  2002-02       Impact factor: 6.741

6.  Regulation and role of Sox9 in cartilage formation.

Authors:  C Healy; D Uwanogho; P T Sharpe
Journal:  Dev Dyn       Date:  1999-05       Impact factor: 3.780

7.  Two endothelin 1 effectors, hand2 and bapx1, pattern ventral pharyngeal cartilage and the jaw joint.

Authors:  Craig T Miller; Deborah Yelon; Didier Y R Stainier; Charles B Kimmel
Journal:  Development       Date:  2003-04       Impact factor: 6.868

8.  Sox9 is required for cartilage formation.

Authors:  W Bi; J M Deng; Z Zhang; R R Behringer; B de Crombrugghe
Journal:  Nat Genet       Date:  1999-05       Impact factor: 38.330

9.  The role of chordin/Bmp signals in mammalian pharyngeal development and DiGeorge syndrome.

Authors:  Daniel Bachiller; John Klingensmith; Natalya Shneyder; Uyen Tran; Ryan Anderson; Janet Rossant; E M De Robertis
Journal:  Development       Date:  2003-08       Impact factor: 6.868

10.  The murine Bapx1 homeobox gene plays a critical role in embryonic development of the axial skeleton and spleen.

Authors:  C Tribioli; T Lufkin
Journal:  Development       Date:  1999-12       Impact factor: 6.868

View more
  1 in total

Review 1.  Mechanisms of synovial joint and articular cartilage development.

Authors:  Ryota Chijimatsu; Taku Saito
Journal:  Cell Mol Life Sci       Date:  2019-06-14       Impact factor: 9.261

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.